ArchPoint Investors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Hold |
29,875
| – | – | 0.73% | 34 |
|
|
2025
Q1 | $2.42M | Buy |
29,875
+875
| +3% | +$71K | 0.8% | 30 |
|
|
2024
Q4 | $2.61M | Sell |
29,000
-875
| -3% | -$78.8K | 0.86% | 28 |
|
|
2024
Q3 | $2.95M | Sell |
29,875
-14,618
| -33% | -$1.44M | 0.99% | 23 |
|
|
2024
Q2 | $4.12M | Hold |
44,493
| – | – | 1.55% | 18 |
|
|
2024
Q1 | $4.22M | Buy |
+44,493
| New | +$4.22M | 1.76% | 18 |
|
|
2021
Q2 | – | Sell |
-7,000
| Closed | -$950K | – | 115 |
|
|
2021
Q1 | $950K | Hold |
7,000
| – | – | 0.27% | 58 |
|
|
2020
Q4 | $985K | Hold |
7,000
| – | – | 0.27% | 56 |
|
|
2020
Q3 | $780K | Hold |
7,000
| – | – | 0.25% | 52 |
|
|
2020
Q2 | $784K | Hold |
7,000
| – | – | 0.25% | 38 |
|
|
2020
Q1 | $542K | Hold |
7,000
| – | – | 0.21% | 51 |
|
|
2019
Q4 | $666K | Hold |
7,000
| – | – | 0.2% | 54 |
|
|
2019
Q3 | $534K | Hold |
7,000
| – | – | 0.18% | 54 |
|
|
2019
Q2 | $614K | Hold |
7,000
| – | – | 0.19% | 49 |
|
|
2019
Q1 | $634K | Sell |
7,000
-48,896
| -87% | -$4.43M | 0.19% | 49 |
|
|
2018
Q4 | $4.01M | Sell |
55,896
-38,228
| -41% | -$2.74M | 1.39% | 15 |
|
|
2018
Q3 | $9.02M | Buy |
94,124
+1,247
| +1% | +$120K | 2.45% | 7 |
|
|
2018
Q2 | $8.84M | Buy |
92,877
+2,660
| +3% | +$253K | 2.55% | 8 |
|
|
2018
Q1 | $7.92M | Sell |
90,217
-840
| -0.9% | -$73.7K | 2.33% | 7 |
|
|
2017
Q4 | $7.73M | Buy |
91,057
+8,150
| +10% | +$692K | 2.41% | 8 |
|
|
2017
Q3 | $7.18M | Buy |
82,907
+950
| +1% | +$82.2K | 2.29% | 8 |
|
|
2017
Q2 | $6.33M | Buy |
81,957
+44,231
| +117% | +$3.41M | 2.01% | 8 |
|
|
2017
Q1 | $2.62M | Sell |
37,726
-274
| -0.7% | -$19K | 0.98% | 23 |
|
|
2016
Q4 | $2.25M | Buy |
+38,000
| New | +$2.25M | 1.32% | 22 |
|